Q4 2023 · 13F-HR
Athyrium Capital Management, LPholdings as filed
Filed 2024-02-14 · accession 0001123292-24-000048
$68.8M
Reported value
3
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 682143AG7 | OMER 5.25 02/15/26 | Omeros Corp | $46.3M | 67.3% | 72,979,000 | Common | NONE |
| 74319F305 | — | Biora Inc. | $14.8M | 21.4% | 10,929,762 | Common | SOLE |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $7.8M | 11.3% | 1,792,114 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.